FDA sends warning letters to companies claiming to treat Alzheimer’s


The Food and Drug Administration said Monday it sent warning letters to more than a dozen companies the agency said are “illegally selling” products that claim to prevent or cure Alzheimer’s disease.

Many of these products, which which are often sold on websites and social media platforms, “have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat,” the FDA said in a press release.

“These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment,” the agency added.

As many as 5.5 million Americans over the age of 65 suffer from Alzheimer’s, a progressive disease that often impacts memory, thinking and behavior. And the number of Americans with the disease is expected to grow, according to the Department of Health & Human Services.

The FDA said the products, which FDA Commissioner Scott Gottlieb labeled a “scam,” have come in the form tablets, capsules and oils. The 17 companies who were sent letters have been asked to respond within 15 days.

Source link

Products You May Like

Articles You May Like

A wealth of investing knowledge awaits at the Warren Buffett archive
Garmin forecasts higher full-year revenue, shares rise
Fidelity notches record profit and revenue
JP Morgan economists now see the economy growing at just 1.5% pace this quarter
Domino’s shares slide after same-store sales growth disappoints

Leave a Reply

Your email address will not be published. Required fields are marked *